baber/WOPTO huggingface dataset:
Patent NZ-508764-A (NZ)
Title: An optofibre cable
Inventor: OLSSON BERTIL
IPC: G02B6/44
Filed: 1999-06-14
Abstract: A method for producing an opto cable with a central strain relief core, a glue layer on the surface of the core, a first array of optofibre-containing tubular elements bonded to the core by the glue layer, and a porous filing material filling the space between the tubular elements and the glue on the surface of the strain relief core. At least a second array of optofibre-containing tubular elements is bonded to the first array by surrounding the first array of tubular elements and the filling material with a layer of glue which bonds the second array of tubular elements to the structure. Filling material is added between the tubular elements of the second array and the layer of glue. Additional concentric arrays of glue layers, tubular elements, and filling material can be added in the same manner. A casing surrounds the outermost concentric array of tubular elements
Patent NZ-509020-A (NZ)
Title: Virtual EPROM simulator apparatus
Inventor: CURTIS KEITH EDWIN
IPC: G06F17/00
Filed: 1999-06-24
Abstract: An apparatus for simulating the internal configuration of industry standard ROM and EPROM-type chips using other types of storage technologies, while still operating transparently with interfaces and mechanisms such as authentication devices adapted to EPROM-type media, includes an EPROM connector interface, a data presentation program; user access log display program; a user login/registration program; a software/data library; software/data selection program; and software/data loader program. These components work in conjunction to securely retrieve software images resident in mass storage media and to present them to an authentication device as if the images were resident in EPROM type media. The apparatus is particularly adapted to use in the gaming industry where regulation and fraud detection are performed using EPROM authentication techniques.
Patent NZ-518034-A (NZ)
Title: Fusidic acid derivatives, pharmaceutical compositions and uses
Inventor: DUVOLD TORE
IPC: A61P31/00
Filed: 2000-10-12
Abstract: Described is a compound of the formula Ia, where: Q1, Q2 and Q3 are the same or different and independently represent a -(CO)- group; a -(CHOH)- group; a -(CHOR)- group; a -(CHSH)- group; a -(NH)- group; a -(CHNH2)- group; or a -(CHNHR)- group, wherein R represents an alkyl radical having 1 to 4 carbon atoms or an acyl radical having 1 to 4 carbon atoms; and wherein Q2 and Q3 may also independently represent a -(CH2)- group; Y is hydrogen, hydroxy, an alkyl radical having 1 to 4 carbon atoms, or an acyl radical having 1 to 4 carbon atoms; A represents an oxygen or sulphur atom; R1 is an alkyl radical having 1 to 4 carbon atoms, an olefinic group having 2 to 4 carbon atoms, a (C1-C6)acyl group, a (C3-C7)cycloalkylcarbonyl group or a benzoyl group, R1 optionally being substituted with one or more halogen atoms and/or hydroxy, alkoxy or azido groups. Also described are pharmaceutical compositions comprising the compound of formula Ia as defined above. The compounds of formula Ia are useful for medical treatment, especially for the systemic treatment of infections.
Patent NZ-519844-A (NZ)
Title: Modified release pharmaceutical composition containing bupropion HCI as active substance
Inventor: VALDUCCI ROBERT
IPC: A61K47/44
Filed: 2002-06-27
Abstract: Sustained release pharmaceutical composition in tablet form  comprising Bupropion HCl as the active substance;  and containing   hydroxypropylmethylcellulose,   stearic   acid, carnauba  wax  and  an  excipient  such  as  lactose  as  an admixture.
Patent NZ-523075-A (NZ)
Title: Thrombin receptor antagonists
Inventor: CHACKALAMANNIL SAMUEL
IPC: A61P3/10
Filed: 2001-06-13
Abstract: Thrombin receptor antagonists or protease activated receptor (PAR) antagonists of formula (I) useful in the treatment of diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, cerebral ischemia, stroke, neurodegenerative diseases and cancer. Also disclosed are pharmaceutical compositions containing said compounds and their use as thrombin receptor antagonists and binders to cannabinoid receptors.
Patent NZ-525647-A (NZ)
Title: Compositions and methods for the modification of gene expression using plant promoters nucleotide sequences
Inventor: PERERA RANJAN
IPC: C12N15/82
Filed: 2000-02-24
Abstract: An isolated polynucleotide comprises the sequence shown in SEQ ID NO:12, a plant O-methyl transferase ( OMT ) promoter sequence from Eucalyptus grandis. DNA constructs comprising the polynucleotides, methods for using such constructs in modulating the gene expression and phenotype of a target organism and plants comprising such constructs are described.
Patent NZ-532707-A (NZ)
Title: Directly compressible formulations of azithromycin
Inventor: MURPHY BRENDAN JOHN
IPC: A61K9/20
Filed: 2002-12-09
Abstract: Disclosed herein is a dry blend used for forming azithromycin tablets by direct compression that comprises (a) 1-80%, by weight non-dihydrate azithromycin; (b) at least one pharmaceutically acceptable excipient; and (c) from 0.25-10%, by weight, of a lubricant; wherein the Carr?s Compressibility Index, of the dry blend, is less than 34%.
Patent NZ-533695-A (NZ)
Title: Calcitrol compositions which have a greater Cmax and a shorter Tmax compared with other synthetic vitamin D preparations
Inventor: FAN JUN
IPC: A61P35/00
Filed: 2004-06-25
Abstract: Disclosed herein is a liquid or semisolid pharmaceutical composition that comprises an active vitamin D compound, a lipophilic phase component, a surfactant, and one or more antioxidants, wherein said compositions provides enhanced stability at high concentrations of said active vitamin D compound.
Patent NZ-534180-A (NZ)
Title: Electric water heater having balanced wattage density water heating
Inventor: JACKSON BARRY N
IPC: F24H1/20
Filed: 2004-07-19
Abstract: An electric water heater (10) has a tank portion (12) in which water (14) to be heated is stored. The stored water is heated by a vertically spaced plurality of electric heating elements (26, 28) extending into the tank interior. The heating elements (26, 28) are of unequal wattages, and serve unequal volume water zones (Z1, Z2) but provide equal heating wattage densities in each of the water zones.
Patent NZ-534331-A (NZ)
Title: Starter assembly for a gas discharge lamp using a control unit to actuate a switch for a predetermined length of time
Inventor: MOLLEMA SCOTT A
IPC: H01J61/56
Filed: 2003-02-18
Abstract: A gas discharge lamp that includes a lamp, a lamp circuit and an outer lamp sleeve, the lamp circuit including the lamp filaments and a power supply, is provided with a starter assembly. The starter assembly includes a switch 34, such as a normally open magnetic switch, located within the outer sleeve of the lamp and coupled between the power supply and the filaments 36a, 36b, and a control unit 100 such as an electromagnet actuator 110 and a microprocessor that is operable to actuate the switch for a predetermined length of time.
Patent NZ-537504-A (NZ)
Title: Process for preparing quinolone antiobiotic intermediates
Inventor: RANDALL JARED LYNN
IPC: C07D215/00
Filed: 2003-08-05
Abstract: Disclosed herein is a process for preparing a quinolone antibiotic intermediate having the formula (I): wherein R is C1-C2 alkyl, C1-C2 fluoroalkyl, C2-C4 alkenyl, methoxy, chloro, or bromo; R1 is a unit selected from the group consisting of C1-C2 alkyl, C2-C3 alkenyl, C3-C5 cycloalkyl, and phenyl, each of which can be substituted by one or more fluorine atoms; said process comprising the step of cyclizing an admixture of quinolone precursors, said admixture comprising a 2-ethoxy substituted intermediate having the formula (II) in the presence of a silylating agent.
Patent NZ-538222-A (NZ)
Title: 2-Thio-substituted imidazole derivatives and their use in pharmaceuticals
Inventor: LAUFER STEFAN
Filed: 2003-08-20
Abstract: Disclosed herein are 2-thio-substituted imidazole derivatives of formula (I), wherein the radicals R1, R2, R3 and m are as defined in the specification. These compounds comprise an immunomodulatory action and/or an action that inhibits the release of cytokines and are thus suited for treating diseases associated with a disorder of the immune system.
Patent NZ-543015-A (NZ)
Title: 4-Anilino-quinazoline derivatives for producing antiproliferative effect by inhibiting erbB2 receptor tyrosine kinase
Inventor: BRADBURY ROBERT HUGH
IPC: C07D417/12
Filed: 2004-04-20
Abstract: A 4-anilino-quinazoline derivative of the formula (I) is disclosed, wherein the substituents are as defined in the specification. The compound of formula (I) is suitable for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm blooded animal such as man.
Patent NZ-548109-A (NZ)
Title: Toroidal intersecting vane machines incorporating intersecting rotors
Inventor: BAILEY STERLING H
IPC: F02B53/04
Filed: 2004-12-21
Abstract: A toroidal intersecting vane machine, which comprises a supporting structure having an inside surface, a first rotor and at least one intersecting second rotor rotatably mounted in the supporting structure, wherein: (a) the first rotor has a plurality of first vanes positioned on a radially inner peripheral surface of the first rotor, with spaces between the first vanes and the surface defining a plurality of primary chambers; (b) an intake port which permits flow of a fluid into the primary chamber and an exhaust port 232 which permits exhaust of the fluid out of the primary chamber; the second rotor has a plurality of secondary vanes positioned on a radially outer peripheral surface of the second rotor, with spaces between the secondary vanes and the surface defining a plurality of secondary chambers 208; a first axis of rotation of the first rotor and a second axis of rotation of the second rotor arranged so that the axes of rotation do not intersect, the first rotor, the second rotor, first vanes and secondary vanes being arranged so that the first vanes and the secondary vanes intersect at only one location during their rotation; and (e) wherein the secondary vanes positively displace the primary chambers and pressurize the fluid in the primary chambers and the primary vanes positively displace the fluid in the secondary chambers 208 and do not substantially pressurize the fluid in the secondary chambers 208.
Patent NZ-551559-A (NZ)
Title: Animal instrumentation
Inventor: DAVIES MICHAEL ALLAN
IPC: A61B5/103
Filed: 2005-05-24
Abstract: A system for monitoring an animal comprises a sensor subsystem for fixing to the animal; a computing subsystem for real-time processing of data provided by the sensor subsystem; and a communication subsystem coupling the sensor subsystem and the computing subsystem for passing sensor data from the sensor subsystem to the processing subsystem. The sensor subsystem includes at least one sensor for measuring a physical parameter associated with at least one limb of the animal. The subsystem is adapted to provide data sufficient for determining at least a trajectory of the limb of the animal. The communication subsystem can include a communication hub for attaching to an animal. The communication hub includes a receiver for accepting sensor data from sensors attached to the animal and a transmitter for providing data based on the accepted sensor data. The sensor subsystem can include a plurality of sensors with each including a transmitter for providing sensor data to the hub. The communication hub is configurable for receiving sensor data from a selection of the plurality of sensors attached to the animal.
Patent NZ-552715-A (NZ)
Title: Galenic applications of self-emulsifying mixtures of lipidic excipients
Inventor: PACHOT JEAN
IPC: A61K9/107
Filed: 2005-07-20
Abstract: Disclosed is the use of self-emulsifying mixtures (SEEDS: Self Emulsifying Drug Delivery System) comprising lipid excipients selected from the group consisting of glyceryl linoleate, glyceryl mono-oleate, glyceryl oleate/linoleate, glyceryl laurate, polyglyceryl-3 oleate, soybean oil, capric/caprylic/lauric acid triglycerides, and oleic acid in an amount of 40 to 85 %, surfactants in an amount of 15 to 50%, and optionally cosurfactants and at least one active principle, for the preparation of a pharmaceutical composition for enhancing the absorption of the active principles by enhancing the absorption of the active principle by a mechanism involving inhibition of efflux pumps, wherein the pharmaceutical composition is to be administered orally. Also disclosed are pharmaceutical compositions comprising said SEEDS and a process for the preparation of said pharmaceutical compositions.
Patent NZ-555178-A (NZ)
Title: Pharmaceutical preparation comprising EPO for the treatment of FriedreichÆs ataxia
Inventor: SCHEIBER-MOJDEHKAR BARBARA
IPC: A61P21/00
Filed: 2005-10-27
Abstract: Disclosed is the use of human erythropoietin or a derivative thereof having the biological activity of human erythropoietin of increasing the expression of frataxin for the production of a pharmaceutical preparation for the treatment of Friedreich's ataxia or a disease associated therewith in a patient suffering from Friedreich's ataxia.
Patent NZ-556173-A (NZ)
Title: Improvements in and relating to night lights
Inventor: PRUDEN SHONA LURLINE
IPC: F21V21/008
Filed: 2007-06-25
Abstract: A night light 10 having a body which supports a light source 17, a battery charger 19 and a photovoltaic or solar cell 15, the body being adapted to house a rechargeable battery and the night light 10 being configured to recharge the battery using the photovoltaic or solar cell 15 and the battery charger 19 when in use, and wherein the night light 10 also includes means adapted to suspend the night light 10 from, or adjacent to, a window.
Patent NZ-562558-A (NZ)
Title: A nitrite gas-forming agent for cement compostion
Inventor: FURUSAWA TAKAO
IPC: C04B22/08
Filed: 2006-06-06
Abstract: Disclosed is a cement composition containing nitrite, comprising a gas-forming agent which produces nitrogen gas through a reaction in the cement composition, selected from sulfonyl hydrazide compounds and nitroso compounds. This cement composition is designed to prevent shrinkage.
Patent NZ-566051-A (NZ)
Title: Screening of inert solids from a low-yield wastewater treatment process
Inventor: CURTIS BETTY-ANN
IPC: C02F3/12
Filed: 2006-08-31
Abstract: Disclosed is a wastewater treatment method comprising: combining wastewater comprising readily degradable solids and inert solids with bacteria-laden sludge in a mainstream reactor to form a mixed liquor; separating the mixed liquor into a clarified effluent and an activated sludge; returning a first portion of activated sludge to the mainstream reactor; and treating a second portion of activated sludge in a sidestream bioreactor prior to returning the second portion of activated sludge to the mainstream reactor; wherein at least a portion of the material returned to the mainstream reactor is passed through a screening device to remove at least a portion of the inert solids.
Patent NZ-571132-A (NZ)
Title: Humanized monoclonal antibodies to hepatocyte growth factor (HGF)
Inventor: KIM KYUNG JIN
IPC: A61K39/395
Filed: 2007-03-28
Abstract: Discloased is a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Patent NZ-573326-A (NZ)
Title: Solvent system for the preparation of n-alkyl thiophosphoric triamide solutions, composition containing n-alkyl thiophosphoric triamide and the use thereof
Inventor: CIGLER PETR
IPC: C05C9/00
Filed: 2007-06-07
Abstract: Disclosed is a composition comprising N-alkyl thiophosphoric triamide which comprises at least one N-alkyl thiophosphoric triamide and a solvent system containing one or more glycol ethers of the general formula (I), wherein the substituents are disclosed in the specification. Also disclosed is the use of the said composition as an urease inhibitor in urea-containing fertilizers.
Patent NZ-573510-A (NZ)
Title: Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
Inventor: ALIG BERND
IPC: C07D401/14
Filed: 2007-06-06
Abstract: Disclosed is a heteroaromatic diamide compound of formula (I) wherein the substituents are as disclosed in the description. An example of a compound of formula (I) is 5-(3,5-Bis-trifluoromethylpyrazol-1-ylmethyl)-2-(3-chloropyridin-2-yl)-2H-pyrazole-3-carboxylic acid 4-chloro-2-methyl-6-methylcarbamoylphenyl amide. Also disclosed is a process for preparing a compound of formula (I) and the intermediates used in the process. Further disclosed is the use of compound to treat seeds, to control pests, to treat transgenic plants and a seed treated with the compound of formula (I).
Patent NZ-573556-A (NZ)
Title: Regulation of transforming growth factor-beta (tgf-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
Inventor: BRIGHTON CARL T
IPC: A61N1/32
Filed: 2007-05-29
Abstract: Disclosed is a device for the treatment of a bone fracture, fracture at risk, delayed union, nonunion, bone defect, spine fusion, osteonecrosis, osteoporosis, comprising: a signal source that generates at least one specific and selective electric signal having a frequency from 30 kHz to 120 kHz, a field generating device connected to the signal source so as to receive at least one specific and selective signal and that is operatively disposed with respect to targeted tissue, the field generating device upon receipt of the at least one specific and selective electric signal causing the generation of a specific and selective an electric field having an amplitude of about 0.2 to 80 mV /cm in the targeted tissue that is specific and selective for up-regulating substantially up-regulates the gene expression of TGF-â1, â2, and/or â3 protein in the targeted tissue as measured by mRNA, and the signal source controlling and varying the duration of time of application of said at least one specific and selective signal for a duration of time from approximately half hour to 24 hours per 24 hour period and controlling and varying the duty cycle of the at least one specific and selective signal applied to the field generating device from approximately 10% to 100% so as to selectively up-regulate gene expression of TGF-â1, â2, and/or â3 in the targeted tissue as a result of upon application of the at least one specific and selective electric field thereto for a pre-determined duration of time at predetermined intervals, a portable power unity that drives the signal source in the first and second modes, an output signal in the first mode causing the generation of a 20mV/cm field in the targeted tissue for a selected period of time, and an output signal in the second mode causing the generation of a 40mV/cm field in the targeted tissue for another selected period of time.
Patent NZ-574623-A (NZ)
Title: Process for the purification of fc-fusion proteins
Inventor: EON-DUVAL ALEX
IPC: A61K38/02
Filed: 2007-08-27
Abstract: Disclosed is a method for purifying an Fc-fusion protein having an isoelectric point from 6.9 to 9.5 comprising the steps of Protein A or Protein G affinity chromatography, cation exchange, anion exchange and hydroxyapatite chromatography and collecting the eluate to obtain purified Fc-fusion protein.
Patent NZ-575703-A (NZ)
Title: Pesticidal composition comprising a synthetic compound useful as nodulation agent of leguminous plants and a fungicide compound
Inventor: SUTY-HEINZE ANNE
IPC: A01N43/88
Filed: 2007-12-11
Abstract: Disclosed is a composition comprising an oligosaccharide derivative represented by general formula (I) and a fungicide selected from benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M, ofurace, oxadixyl, azoxystrobin, dimoxystrobin, fluoxastrobin, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, azaconazole, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, furconazole, furconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazol, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole triticonazole, uniconazole, viniconazole, 5 voriconazole and N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide. A method for controlling phytopathogenic fungi of crops and increasing the yield of crops is also disclosed. The method involves applying the above composition via seed treatment, foliar application, stem application or drench/drip application (chemigation) to the seed, the plant and/or to the fruit of the plant or to soil and/or to inert substrate, Pumice, Pyroclastic materials/tuff, synthetic organic substrates, organic substrates and/or to a liquid substrate in which the plant is growing or in which it is desired to grow.
Patent NZ-581008-A (NZ)
Title: Membrane cleaning with pulsed airlift pump
Inventor: ZHA FUFANG
IPC: B01D61/18
Filed: 2008-05-29
Abstract: Disclosed is a membrane module comprising a plurality of porous membranes (6) and a device for providing randomly generated pulsed fluid flow. The device includes a gaslift pump (11) apparatus operative in response to a supply of pressurized gas from a gas source connected thereto to store and intermittently release pressurized gas. The released gas is used to gaslift quantities of the liquid from a reservoir of liquid to produce a pulsed two phase gas/liquid flow along surfaces of the membranes to dislodge fouling materials therefrom. The gaslift pump apparatus includes an inverted gas storage chamber (12) for storing the gas and having a closed upper end and an open lower end (13) positioned in the reservoir of liquid. A vertical riser tube (15) located within said gas has an opening in fluid communication with the gas storage chamber. When the level of gas within the chamber reaches a predetermined level, the gas is released and gaslifts the liquid through the riser tube for discharge into the module.
Patent NZ-583428-A (NZ)
Title: Selective-sorting harvesting machine for berries with a vision system
Inventor: PELLENC ROGER
IPC: A01D46/28
Filed: 2008-09-05
Abstract: A selective sorting machine is disclosed for berry crops consisting of healthy, ripe, whole, unripe, shattered, overripe, botrytized, crushed or burst berries, leaves, stalks, various debris and sticky juice. The machine includes a supply system (3, 4, 5) suitable for feeding the crop to a vision system (6, 7, 8, 9). The supply system is fitted to spread the crop in a single layer, align, individually isolate and move the components at a regulated speed so the crop components pass individually through the vision system. The vision system includes an artificial vision device (6) capable of acquiring images of the crop components as they exit the supply system and a lighting system (7) for illuminating the crop components. The vision system is configured to individualize and recuperate in space each element to control a selective separating system (10) via a processing device (8). The processing device (8) is capable of analysing the images to recognize and differentiate the components on the basis of pre-established criteria. The selective separating system (10) then separates healthy, ripe and whole berries from the other crop components.